ArticlePloS one2017

Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.

Yi-Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.